Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Post by MoneyMouthon Apr 02, 2022 5:49pm
287 Views
Post# 34570468

Perspective

Perspective
Just to give some perspective, in like July of 2016, Sernova announced that the JDRF would help sponsor and bring the cell pouch towards their first in-human clinical trial.

In December 2017, a year and a half later, the FDA approved and authorized the initiation of the first in-human clinical trial.

In December of 2018, the first patient was enrolled in that study. 1 full year later.

In January of 2021, Three years later, that first patient was announced as insulin independence. And what was started 4 years prior had finally bared fruit, share prrice wise.

Now we are in 2022, and suddenly we ask ourselves why is management so slow?? Did we ask these questions in 2017? Or 18? Yeah! Did anything change? No not really.

Unless something changes, past performance is a good indicator of future performance. So strap in until 2025...
<< Previous
Bullboard Posts
Next >>